A new way to use transit-time flow measurement for coronary artery bypass grafting.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
10 05 2021
Historique:
received: 17 03 2020
revised: 30 07 2020
accepted: 21 10 2020
pubmed: 24 1 2021
medline: 7 10 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

Transit-time flow measurement is a recognized method for graft evaluation in coronary surgery. However, single flow measurement has been associated with a low specificity for detecting graft dysfunction. The goal of this study was to assess the value of transit-time flow measurement for assessing in situ internal mammary artery grafts during non-existent native coronary circulation and the relevance of collateral blood flow in target vessels. Between 2014 and 2018, a total of 134 patients undergoing on-pump coronary artery bypass grafting were evaluated using transit-time flow measurement. We analysed 111 single left internal mammary artery and 57 single right internal mammary artery bypasses. Correlations between coronary relevant parameters were calculated using Spearman's ρ coefficient. Risk factors for decreased flow with an arrested heart (FAH) <30 ml/min and an increased pulsatility index (PI) >3.0 as well as flow reduction >30% were calculated. FAH correlated with the diameter of the target vessel (Spearman's ρ = 0.32; P < 0.001), the amount of blood distribution (Spearman's ρ = 0.34; P < 0.001), the PI (Spearman's ρ = 0.19; P = 0.019) and the degree of stenosis (Spearman's ρ = -0.17; P = 0.042). The percentage of flow change was found to correlate with the PI (Spearman's ρ = -0.47; P < 0.0001), the degree of stenosis (Spearman's ρ = 0.42; P < 0.001), the diameter of the target vessel (Spearman's ρ = -0.22; P = 0.008) and the area of blood distribution (Spearman's ρ = -0.19; P = 0.018). A small blood distribution area was the only risk factor for decreased FAH [odds ratio (OR) 8.43, confidence interval (CI) 95% (3.04-23.41); P < 0.001]. Binary logistic regression identified PI [OR 2.05, CI 95% (1.36-3.10); P = 0.001], FAH [OR 0.98, CI 95% (0.97-0.99); P = 0.005] and degree of stenosis [OR 0.95, CI 95% (0.92-0.99); P = 0.011] as risk factors for decreased flow after cardiopulmonary bypass (<30 ml/min). An increased PI (>3) was mainly influenced by percentage of flow change [OR 0.99, CI 95% (0.98-1.00); P = 0.031]. FAH and percentage of flow change are related to the dimensions of the target vessel and the degree of stenosis. The addition of flow measurements with the heart arrested provides additional information about the bypass graft, the quality of the anastomosis and the physiology of the coronary circulation.

Identifiants

pubmed: 33484126
pii: 6114701
doi: 10.1093/icvts/ivaa328
pmc: PMC8691568
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

711-718

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

Ann Thorac Surg. 2008 Feb;85(2):494-9; discussion 499-500
pubmed: 18222251
J Thorac Cardiovasc Surg. 2006 Sep;132(3):585-94
pubmed: 16935114
Eur J Cardiothorac Surg. 2014 Oct;46(4):517-92
pubmed: 25173601
Ann Thorac Surg. 2008 Aug;86(2):532-6
pubmed: 18640329
Eur Heart J. 2019 Aug 1;40(29):2421-2428
pubmed: 31155673
EuroIntervention. 2019 Dec 06;15(11):e999-e1005
pubmed: 31270037
Curr Opin Cardiol. 2017 Nov;32(6):722-736
pubmed: 28806185
Heart Surg Forum. 1999;2(2):121-4
pubmed: 11276468
Eur J Cardiothorac Surg. 2000 Mar;17(3):287-93
pubmed: 10758390
Innovations (Phila). 2013 Nov-Dec;8(6):416-9
pubmed: 24356431
Interact Cardiovasc Thorac Surg. 2011 Jun;12(6):993-7; discussion 997
pubmed: 21441253
Eur J Cardiothorac Surg. 2010 Aug;38(2):155-62
pubmed: 20176493
Ann Thorac Surg. 2007 Dec;84(6):1928-33
pubmed: 18036908
J Am Coll Cardiol. 2018 Dec 4;72(22):2732-2743
pubmed: 30497559
Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):582-5
pubmed: 18467427
J Thorac Cardiovasc Surg. 2015 Jun;149(6):1622-8
pubmed: 25840755
J Thorac Cardiovasc Surg. 2005 Aug;130(2):315-20
pubmed: 16077393
Eur J Cardiothorac Surg. 2007 Aug;32(2):313-8
pubmed: 17555979
Scand Cardiovasc J. 2002 Mar;36(2):95-9
pubmed: 12028872
Curr Opin Cardiol. 2008 Nov;23(6):568-72
pubmed: 18830071
Circ Cardiovasc Interv. 2018 Jun;11(6):e006368
pubmed: 29848611
Ann Thorac Surg. 2007 Jun;83(6):2093-7
pubmed: 17532405
Interact Cardiovasc Thorac Surg. 2010 Nov;11(5):635-40
pubmed: 20682631
J Thorac Cardiovasc Surg. 2006 Sep;132(3):468-74
pubmed: 16935097
Eur J Cardiothorac Surg. 2011 Jun;39(6):918-23
pubmed: 21095134
Int J Legal Med. 1999;112(2):107-14
pubmed: 10048668
J Card Surg. 2015 Jan;30(1):47-52
pubmed: 25363805
Eur J Cardiothorac Surg. 2014 Mar;45(3):e41-5
pubmed: 24335472
Eur J Cardiothorac Surg. 1998 Nov;14(5):476-9
pubmed: 9860203

Auteurs

Lukas Stastny (L)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Markus Kofler (M)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Vitalijs Zujs (V)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Elfriede Ruttmann (E)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Julia Dumfarth (J)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Juliane Kilo (J)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Alexandra Brix (A)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Simone Gasser (S)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Adel Sakic (A)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Thomas Schachner (T)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Michael Grimm (M)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Nikolaos Bonaros (N)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH